Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-23 8:20 pm Sale | 2024-12-23 | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 1,603,593 4.900% | -2,821,846 (-63.76%) | Filing History |
| 2024-11-14 5:14 pm Sale | 2024-09-30 | 13G | ORIC Pharmaceuticals, Inc. ORIC | COLUMN GROUP II LP | 3,644,118 5.200% | -27,404 (-0.75%) | Filing History |
| 2023-11-22 4:16 pm Sale | 2023-11-15 | 13D | eFFECTOR Therapeutics, Inc. EFTR | COLUMN GROUP II LP | 0 0.000% | -163,669 (Position Closed) | Filing History |
| 2023-09-15 4:05 pm Sale | 2023-06-15 | 13D | eFFECTOR Therapeutics, Inc. EFTR | COLUMN GROUP II LP | 163,669 6.600% | -8,704 (-5.05%) | Filing History |
| 2023-01-13 4:50 pm Purchase | 2022-05-10 | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 4,425,439 13.100% | 1,269,211 (+40.21%) | Filing History |
| 2022-02-11 4:54 pm Sale | 2021-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | COLUMN GROUP II LP | 3,671,522 9.300% | -1,096,659 (-23.00%) | Filing History |
| 2021-09-20 5:18 pm Sale | 2021-09-10 | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 3,156,228 10.700% | -1,201,019 (-27.56%) | Filing History |
| 2021-09-07 5:12 pm Purchase | 2021-08-25 | 13D | eFFECTOR Therapeutics, Inc. EFTR | COLUMN GROUP II LP | 172,373 10.600% | 172,373 (New Position) | Filing History |
| 2021-08-30 5:21 pm Sale | 2021-08-18 | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 4,357,247 14.800% | -1,295,750 (-22.92%) | Filing History |
| 2021-02-12 6:24 pm Purchase | 2020-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | COLUMN GROUP II LP | 4,768,181 13.100% | 4,768,181 (New Position) | Filing History |
| 2021-02-12 6:12 pm Sale | 2020-12-31 | 13G | GRITSTONE BIO INC GRTSQ | COLUMN GROUP II LP | 0 0.000% | -3,102,934 (Position Closed) | Filing History |
| 2020-11-04 4:52 pm Sale | 2020-08-20 | 13G | Arcus Biosciences, Inc. RCUS | COLUMN GROUP II LP | 0 0.000% | -3,540,850 (Position Closed) | Filing History |
| 2020-10-01 4:15 pm Sale | 2020-09-22 | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 5,652,997 23.100% | -608,000 (-9.71%) | Filing History |
| 2020-08-26 4:42 pm Sale | 2020-08-17 | 13D | RAPT Therapeutics, Inc. RAPT | COLUMN GROUP II LP | 6,260,997 25.600% | -516,154 (-7.62%) | Filing History |